enfortumab,Pembrolizumab,cisplatin,carboplatin,gemcitabine
Astellas,Merck,Seagen
['urothelial carcinoma', 'cisplatin', 'urothelial', 'enfortumab', 'gucancer', 'pembro', ' vedo', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'astellas', 'seattlegenetics']
enfortumab vedotin-ejfv plus pembrolizumab induced durable responses in cisplatin-ineligible urothelial carcinoma. we spoke with of to learn more. #asco23 #gucancer 
The content you need, when you need it.